Friday, May 29, 2015

Gene Test May Predict Success of Cancer Drug in Certain Patients

… with colon cancer, 62 percent of those with MMR-deficient tumors showed tumor shrinkage when taking Keytruda, compared with no tumor shrinkage … types of cancers, including colon (colorectal), stomach, small bowel, prostate, ovarian and …

No comments:

Post a Comment